Article Information
History
- August 31, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Balu Bhasuran, PhD1,*,
- Katharina Schmolly, BS2,*,
- Yuvraaj Kapoor3,
- Nanditha Lakshmi Jayakumar, MBBS3,
- Raymond Doan, PharmD4,
- Jigar Amin, PharmD4,
- Stephen Meninger, PharmD4,
- Nathan Cheng, PharmD4,
- Robert Deering, PharmD, PhD4,
- Karl Anderson, MD5,
- Simon W. Beaven, MD, PhD2,
- Bruce Wang, MD3,† and
- Vivek A. Rudrapatna, MD, PhD1,6,†
- 1Bakar Computational Health Sciences Institute, San Francisco, CA, 94143
- 2David Geffen School of Medicine & Pfleger Liver Institute, University of California Los Angeles, Los Angeles, CA 90095
- 3Department of Medicine, University of California San Francisco, San Francisco, CA, 94143
- 4Alnylam Pharmaceuticals, Cambridge, Massachusetts, MA 02142
- 5Division of Gastroenterology and Hepatology, University of Texas Medical Branch, School of Medicine, Galveston, TX, 77555
- 6Division of Gastroenterology and Hepatology, Department of Medicine, University of California, San Francisco, San Francisco, CA, 94143
- ↵†Corresponding Authors:
Bruce Wang, MD, Associate Professor of Medicine, 513 Parnassus Ave, HSE #1427, San Francisco, CA 94143, Email: bruce.wang{at}ucsf.edu, Vivek A. Rudrapatna, MD PhD, Assistant Professor of Medicine, University of California, San Francisco Bakar Institute, Box 2993, 490 Illinois Street, Floor 2, San Francisco, CA 94143, Email: vivek.rudrapatna{at}ucsf.edu